Our Testing Method
Broad coverage of different variants
We are using Atila BioSystems' iAMP COVID-19 assay for testing. This assay covers both the OFR1a/b and N genes of the SARS-CoV-2 virus,
making it possible to detect a wider variety of variants. The assay currently detects all of the reported 'variants of interest'.
The test also uses nasal swabs rather than nasopharyngeal or oropharyngeal swabs, making it more comfortable for the patient and less of a burden for medical staff.